ANDREW-JUSTIN TIO: Open Payments
NPI 1730713488 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,323 in 165 payments from 50 companies in 2025. Trend: 2023 $2,965 · 2024 $4,632 · 2025 $4,323
Food & beverage: $3,919Education: $447
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $516 |
| AstraZeneca Pharmaceuticals LP | 11 | $405 |
| Merck Sharp & Dohme LLC | 11 | $295 |
| Novartis Pharmaceuticals Corporation | 9 | $267 |
| Celgene Corporation | 18 | $224 |
| Astellas Pharma US Inc | 6 | $200 |
| SEAGEN INC. | 2 | $175 |
| Incyte Corporation | 4 | $143 |
| PFIZER INC. | 5 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $140 |
Products named: KEYTRUDA, REBLOZYL, RYBREVANT, KISQALI, ERLEADA, POTELIGEO, Enhertu, CALQUENCE.
Industry payments across CA — which companies pay providers there.
